Skip to main content
S 2828 111th Congress Senate Health Administrative law and regulatory procedures Advisory bodies Cancer Department of Health and Human Services Environmental health Hazardous wastes and toxic substances Health promotion and preventive care Hereditary and development disorders Medical education Medical research National Institutes of Health (NIH) Sex and reproductive health Student aid and college costs

Endocrine Disruption Prevention Act of 2009

Introduced: December 3, 2009 See on congress.gov
This bill died when the 111th Congress ended
It never became law before the 111th Congress (2009–2010) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 3, 2009
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 3, 2009
Sponsor introductory remarks on measure. (CR S12324)
Dec 3, 2009
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Endocrine Disruption Prevention Act of 2009 - Amends the Public Health Service Act to require the Director of the National Institute of Environmental Health Sciences to establish the Endocrine Disruption Prevention Program, under which the Director shall: (1) conduct and support multidisciplinary research to improve the understanding of endocrine disruption; and (2) conduct workshops and fora on health effects associated with environmental agents that may affect the endocrine system.

Requires the Director to establish an Endocrine Disruption Program Panel, which shall: (1) provide advice to the Director on the conduct and support of research; (2) evaluate existing population-level biomonitoring and biobanking surveillance and research programs and recommend changes needed to develop data on human exposures and effects to support the Program; and (3) develop a list of chemicals of concern for endocrine disruption effects and make findings with respect to such chemicals. Authorizes individuals to petition the Panel to determine whether a chemical should be listed or to revise a finding or determination based on new information.

Requires the Director, if the Panel finds that data are sufficient to determine that there is at least a minimal level of concern associated with a chemical's potential to disrupt the human endocrine system, to transmit the finding, including the routes and sources of exposure to the chemical, to each federal agency with authority to regulate the chemical. Requires each federal agency that receives such a transmission: (1) to reply to the Director describing the agency's regulatory authority, past actions in connection with the chemical, and proposed action to protect human health from the potential endocrine disruption effects of exposure to the chemical; and (2) within one year, to report on the actions taken and future actions proposed by the Agency in response to the Panel's finding.

Requires the Director to establish a program to support graduate and postdoctoral training in fields related to the prevention of endocrine disruption.

What's happening now December 3, 2009

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2828: Endocrine Disruption Prevention Act of 2009. 111th Congress. Open America. https://openamerica.io/bill/111-S-2828/
MLA
"S. 2828: Endocrine Disruption Prevention Act of 2009." 111th Congress, 2026, Open America, https://openamerica.io/bill/111-S-2828/.
Bluebook (legal)
S. 2828, 111th Cong. (2026), https://openamerica.io/bill/111-S-2828/.
Markdown link
[S. 2828: Endocrine Disruption Prevention Act of 2009](https://openamerica.io/bill/111-S-2828/)
Report a problem